ATH 33.3% 0.4¢ alterity therapeutics limited

Acorda Therapeutics is gambling $525 million on a Phase III-ready Parkinson's treatment, page-4

  1. 790 Posts.
    lightbulb Created with Sketch. 208
    Good question. What comes after a disappointing II(b)? Presumably nothing until the HD approval is secured. But thereafter can we go to a fully funded phase III or is there another intermediate stage?

    Cheetah
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.